Sonnet BioTherapeutics Holdings, Inc.
NASDAQ: SONN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Raghu Rao
- Employees
- 13
- Headquarters
- Princeton, United States
- IPO year
- 2006
- Market cap
- $8.4M
- Website
- https://www.sonnetbio.com
Loading SONN…
Loading profile data…Frequently asked questions about SONN
What does Sonnet BioTherapeutics Holdings, Inc. (SONN) do?
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company based in Princeton, New Jersey, operates in the clinical stage with a primary focus on oncology. The firm is dedicated to developing novel platforms for creating biologic medicines that can exhibit either singular or dual therapeutic mechanisms. Central to their strategy is a proprie...
Where does SONN trade?
Sonnet BioTherapeutics Holdings, Inc. (SONN) trades on the NASDAQ Capital Market.
What sector is SONN in?
Sonnet BioTherapeutics Holdings, Inc. (SONN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sonnet BioTherapeutics Holdings, Inc.?
Raghu Rao is the chief executive officer of Sonnet BioTherapeutics Holdings, Inc. (SONN).
Where is Sonnet BioTherapeutics Holdings, Inc. headquartered?
Sonnet BioTherapeutics Holdings, Inc. is headquartered in United States.
Does SONN pay a dividend?
Sonnet BioTherapeutics Holdings, Inc. (SONN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SONN go public?
Sonnet BioTherapeutics Holdings, Inc. (SONN) completed its initial public offering in 2006.